RT Book, Section
A1 Sharma, Rahul
A1 Brodie, Bruce R.
A1 Henry, Timothy D.
A2 Samady, Habib
A2 Fearon, William F.
A2 Yeung, Alan C.
A2 King III, Spencer B.
SR Print(0)
ID 1146599514
T1 Special Considerations: ST-Segment Elevation Myocardial Infarction
T2 Interventional Cardiology, 2e
YR 2017
FD 2017
PB McGraw-Hill Education
PP New York, NY
SN 9780071820363
LK accesscardiology.mhmedical.com/content.aspx?aid=1146599514
RD 2024/04/20
AB ST-segment  elevation  myocardial  infarction  (STEMI)  composes  approximately  25%  to  40%  of  myocardial  infarction  (MI)  presentations.  There  has  been  remarkable  progress  in  the  treatment  and  clinical  outcomes  in  STEMI  patients  over  the  past  2  decades.  Where  available  within  a  reasonable  time  period,  reperfusion  with  percutaneous  coronary  intervention  (PCI)  has  been  accepted  as  the  preferred  reperfusion  strategy  for  STEMI  (Fig.  37-1).  As  the  number  of  patients  receiving  primary  PCI  has  increased,  mortality  has  declined  (Fig.  37-2).  In-hospital  and  1-year  mortality  rates  are  currently  4%  to  6%  and  7%  to  18%,  respectively.1-4  Few  other  interventions  in  clinical  medicine  require  the  complex  organization  of  health  care  delivery  systems  and  the  high  level  of  technical  expertise  to  achieve  optimum  outcomes.  In  this  chapter,  we  review  the  evidence  for  PCI  in  STEMI,  including  management  of  patients  presenting  to  non–PCI-capable  centers  as  well  as  selected  technical  aspects  of  PCI  including  adjunctive  pharmacotherapy.